Serotiny Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

Serotiny General Information

Description

Operator of a biotechnology platform intended to harmonize computationally aided protein design, high-throughput cellular assays and next-generation sequencing. The company's platform enables a cross-disciplinary approach to engineering large and often unstructured multi-domain proteins, applying expertise from synthetic biology, immunology, machine learning, software engineering and bioinformatics, enabling biotherapeutic partners to access gene and cell therapies and get enhanced safety and efficacy through novel control methods and engineered functionalities.

Contact Information

Website
www.serotiny.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor
  • San Francisco, CA 94080
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Johnson & Johnson
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor
  • San Francisco, CA 94080
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Serotiny Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Apr-2024 Completed Generating Revenue
5. Later Stage VC 20-Mar-2023 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
3. Accelerator/Incubator 10-Mar-2019 Completed Startup
2. Seed Round 10-Jul-2018 $3M $3M Completed Generating Revenue
1. Grant 30-Jun-2016 $150K Completed Generating Revenue
To view Serotiny’s complete valuation and funding history, request access »

Serotiny Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Serotiny’s complete cap table history, request access »

Serotiny Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to harmonize computationally aided protein design, high-throughput cellula
Drug Discovery
San Francisco, CA
16 As of 2024

South San Francisco, CA
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Serotiny Competitors (4)

One of Serotiny’s 4 competitors is ArsenalBio, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ArsenalBio Venture Capital-Backed South San Francisco, CA
Outpace Bio Venture Capital-Backed Seattle, WA
Link Cell Therapies Venture Capital-Backed South San Francisco, CA
Ginkgo Bioworks Formerly VC-backed Boston, MA
To view Serotiny’s complete competitors history, request access »

Serotiny Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Serotiny Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022291384-A1 Synthetic receptor for conditional activation of immune cells Inactive 09-Jun-2021
CA-3225284-A1 Synthetic receptor for conditional activation of immune cells Pending 09-Jun-2021
EP-4352232-A2 Synthetic receptor for conditional activation of immune cells Pending 09-Jun-2021
EP-4352232-A4 Synthetic receptor for conditional activation of immune cells Pending 09-Jun-2021
US-20240285758-A1 Synthetic receptor for conditional activation of immune cells Pending 09-Jun-2021 A61K40/31
To view Serotiny’s complete patent history, request access »

Serotiny Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Serotiny Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
8VC Venture Capital Minority
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority
ND Capital Venture Capital Minority
Angel (individual) Minority
QB3 Accelerator/Incubator Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Serotiny FAQs

  • When was Serotiny founded?

    Serotiny was founded in 2014.

  • Where is Serotiny headquartered?

    Serotiny is headquartered in San Francisco, CA.

  • What is the size of Serotiny?

    Serotiny has 16 total employees.

  • What industry is Serotiny in?

    Serotiny’s primary industry is Drug Discovery.

  • Is Serotiny a private or public company?

    Serotiny is a Private company.

  • What is Serotiny’s current revenue?

    The current revenue for Serotiny is .

  • How much funding has Serotiny raised over time?

    Serotiny has raised $7M.

  • Who are Serotiny’s investors?

    8VC, Johnson & Johnson Innovation - JLABS, ND Capital, , and QB3 are 5 of 6 investors who have invested in Serotiny.

  • Who are Serotiny’s competitors?

    ArsenalBio, Outpace Bio, Link Cell Therapies, and Ginkgo Bioworks are competitors of Serotiny.

  • When was Serotiny acquired?

    Serotiny was acquired on 01-Apr-2024.

  • Who acquired Serotiny?

    Serotiny was acquired by Johnson & Johnson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process